Zobrazeno 1 - 10
of 42
pro vyhledávání: '"V R Peddi"'
Investigator Assessment of the Utility of the TruGraf Molecular Diagnostic Test in Clinical Practice
Autor:
Sunil M. Kurian, Didier A. Mandelbrot, D. Maluf, C. Schieve, D. Lee, John J. Friedewald, A. Patel, James C. Rice, S. Rose, Richard J. Knight, Michael Abecassis, M. R. First, V. R. Peddi, Roslyn B. Mannon, Christopher L. Marsh, P. Lewis, J. David
Publikováno v:
Transplantation Proceedings. 51:729-733
Background TruGraf v1 is a well-validated DNA microarray-based test that analyzes blood gene expression profiles as an indicator of immune status in kidney transplant recipients with stable renal function. Methods In this study, investigators assesse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac36e8627c7dac4fdb9dd696848e9f06
https://doi.org/10.1016/j.transproceed.2018.10.024
https://doi.org/10.1016/j.transproceed.2018.10.024
Autor:
Sunil M. Kurian, J. David, Jamie Case, Bethany Barrick, Roslyn B. Mannon, Christopher L. Marsh, Michael Abecassis, S. Rose, James C. Rice, Didier A. Mandelbrot, Thomas Whisenant, D. Maluf, A. Patel, John J. Friedewald, D. Lee, C. Schieve, Richard J. Knight, M. R. First, V. R. Peddi
Publikováno v:
Transplantation Proceedings. 51:722-728
TruGraf v1 is a laboratory-developed DNA microarray-based gene expression blood test to enable proactive noninvasive serial assessment of kidney transplant recipients with stable renal function. It has been previously validated in patients identified
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96aef12ca09a07f8fbd0d1e1495a39b7
https://doi.org/10.1016/j.transproceed.2019.01.054
https://doi.org/10.1016/j.transproceed.2019.01.054
Autor:
Kevin McCague, Dhavalkumar D. Patel, Shamkant Mulgaonkar, Fuad S. Shihab, David Shaffer, V R Peddi, Y. Qazi
Publikováno v:
American Journal of Transplantation
A key objective in the use of immunosuppression after kidney transplantation is to attain the optimal balance between efficacy and safety. In a phase 3b, multicenter, randomized, open‐label, noninferiority study, the incidences of clinical events,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfb35d8dd654c2e488b5ee511accab00
https://doi.org/10.1111/ajt.14215
https://doi.org/10.1111/ajt.14215
Autor:
Bruce Kaplan, Fuad S. Shihab, Shamkant Mulgaonkar, Kevin McCague, V R Peddi, Dhavalkumar D. Patel, Serdar Yilmaz, F. Luan, Stephen J. Tomlanovich, David Shaffer, Dean Y Kim, Y. Qazi
Publikováno v:
American Journal of Transplantation. 17:1358-1369
In this 12-month, multicenter, randomized, open-label, noninferiority study, de novo renal transplant recipients (RTxRs) were randomized (1:1) to receive everolimus plus low-dose tacrolimus (EVR+LTac) or mycophenolate mofetil plus standard-dose Tac (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa8ba8ab0ff1127ec1e8074998a2c2e5
https://doi.org/10.1111/ajt.14090
https://doi.org/10.1111/ajt.14090
Publikováno v:
American Journal of Kidney Diseases. 31:928-931
Recurrent or de novo glomerular disease is an important cause of graft dysfunction and eventual loss. Cyclosporine A (CyA) has improved short-term renal allograft outcome but has not altered long-term graft survival. The purpose of the current study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2621cf3eb3af08a675eb165a9bc04760
https://doi.org/10.1053/ajkd.1998.v31.pm9631835
https://doi.org/10.1053/ajkd.1998.v31.pm9631835
Publikováno v:
Journal of the American Society of Nephrology. 5:1882-1887
The association between thrombotic events and primary or secondary antiphospholipid/anticardiolipin syndrome is now well recognized. A spectrum of renal involvement ranging from glomerular thrombosis to renal infarction has been described. A case of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::854d4d62e2549c2f6f51023b34fafa32
https://doi.org/10.1681/asn.v5111882
https://doi.org/10.1681/asn.v5111882
Autor:
Robert A. Fisher, T. Shah, Shamkant Mulgaonkar, Goran B. Klintmalm, Sundaram Hariharan, Steven Steinberg, N. Lawendy, Jonathan S. Bromberg, C. Wang, Flavio Vincenti, Daniel C. Brennan, G. Chan, Stephan Busque, V R Peddi, Douglas P. Slakey, Joseph R. Leventhal
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 9(8)
This randomized, pilot study compared the Janus kinase inhibitor CP-690,550 (15 mg BID [CP15] and 30 mg BID [CP30], n = 20 each) with tacrolimus (n = 21) in de novo kidney allograft recipients. Patients received an IL-2 receptor antagonist, concomita
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41d2c020039814fbdd4cf03d15553a3c
https://pubmed.ncbi.nlm.nih.gov/19660021
https://pubmed.ncbi.nlm.nih.gov/19660021
Autor:
V R, Peddi, M R, First
Publikováno v:
Seminars in dialysis. 14(3)
Recent advances in immunosuppression have focused on more effective, safer, and targeted therapies that have resulted in improved short- and intermediate-term renal allograft survival. During the past decade there has been a marked decrease in acute
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8a1157015af039ff981d204d649c7690
https://pubmed.ncbi.nlm.nih.gov/11422929
https://pubmed.ncbi.nlm.nih.gov/11422929
Autor:
S, Hariharan, M B, Adams, D C, Brennan, C L, Davis, M R, First, C P, Johnson, R, Ouseph, V R, Peddi, C J, Pelz, A M, Roza, F, Vincenti, V, George
Publikováno v:
Transplantation. 68(5)
Short-term and long-term results of renal transplantation have improved over the past 15 years. However, there has been no change in the prevalence of recurrent and de novo diseases. A retrospective study was initiated through the Renal Allograft Dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8e9624517519d3b266b5fb39ba4cdb55
https://pubmed.ncbi.nlm.nih.gov/10507481
https://pubmed.ncbi.nlm.nih.gov/10507481
Publikováno v:
Transplantation. 68(5)
We sought to determine whether diagnoses established through the Banff schema for evaluation of renal allograft pathology have implications for clinical management, compared with diagnoses established using descriptive terminology.All patients includ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::52fb91851facb4bcee47c20077f633c1
https://pubmed.ncbi.nlm.nih.gov/10507482
https://pubmed.ncbi.nlm.nih.gov/10507482